IMMUSORBA PH | Asahi Kasei Medical Co., Ltd.

Diseases

Product Line

Filters

Plasmaflo OP

Equipment

PlasautoΣ

Hirata et al.: IMMUSORBA TR and PH.; Ther Apher Dial. 7:85-90, 2003.
Yoshida et al.: IMMUSORBA TR and IMMUSORBA PH: Basics of design and features of functions.; Ther Apher. 4:127-34, 2000.

Gaubitz et al.: Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.; J Autoimmun. 11:495-501, 1998.
Yoshida et al.: IMMUSORBA TR and IMMUSORBA PH: Basics of design and features of functions.; Ther Apher. 4:127-34, 2000.
Yang et al.: Plasma adsorption in critical care.; Ther Apher. 6:184-8, 2002.
Hirata et al.: IMMUSORBA TR and PH.; Ther Apher Dial. 7:85-90, 2003.
Sugimoto et al.: Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.; Ther Apher Dial. 10:187-92, 2006.
Yamaji et al.: Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.; Ther Apher Dial. 12:298-305, 2008.
Loo et al.: Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis.; Transfus Apher Sci. 43:335-40, 2010.

Trademark
IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.

IMMUSORBA PH

Please feel free to send us any questions you may have about our products and support.

Share your feelings and experiences when using our products.

Plasmapheresis: Therapeutic plasmapheresis is an extracorporeal blood purification technique designed for the removal of pathogenic substances from the plasma of patients.

Continuous Renal Replacement Therapy (CRRT): Continuous Renal Replacement Therapy (CRRT) is a slow and continuous extracorporeal blood purification therapy.

Education & training: We offer supervision regarding launch of our products and technical training for each area/country.

This website’s privacy and cookie policies follow Asahi Kasei Group’s policies.